The med-ed company is buying Amazing Charts, a tie-up the firms say will enable them to deliver customized education to physicians and then assess the patient-level impact.
Most docs don’t know about FDA’s opioid safety plan: survey
Only 35% of physicians are aware of the FDA’s class-wide safety plan for certain opioids, a survey showed, suggesting an awareness challenge as the plan gets under way.
The drug industry dialed back its continuing medical education (CME) grant-giving in 2011, continuing a negative trend of the last few years.
People news: ACEHP and Preventice
July 23, 2012
7:04 pm
The Alliance for Continuing Education in the Health Professions (ACEHP) named a new executive director, and mobile health app firm Preventice hired a director of global business development.
The FDA’s opioid REMS safety plan is challenged on two fronts: getting CME providers to offer courses and getting doctors to attend them. Can the agency’s scheme educate enough physicians to curb an epidemic?
Latest ‘edu-game’ taps into internists’ competitive side